Drugs / ACH24
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01419964 | Jan 2012 → Dec 2013 | vitiligo | Ache Laboratorios Farmaceuticos S.A. | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACH24 | “to assess the efficacy of ACH24 in the repigmentation of achromatic areas in patients with vitiligo.” NCT01419964 ↗ |